Effects of aromatase inhibition with aminoglutethimide in men with benign prostatic hypertrophy [Poster 28]

Robin M. Murray, Mitch Dowsett, Mark E. Cooper, Terri J. Allen, Peter Lawson, Harold Story, Rodney Syme

Research output: Contribution to journalArticleOtherpeer-review

3 Citations (Scopus)


Fourteen men with benign prostatic hypertrophy were treated with the aromatase inhibitor aminoglutethimide for periods of up to 3 months. LH, FSH and testosterone levels rose within one week and remained elevated, while estradiol levels decreased. Despite significant changes in these hormones there was no change in urine flow rates or prostatic size over the study period.

Original languageEnglish
Pages (from-to)647-648
Number of pages2
Issue number4-6
Publication statusPublished - 1 Jan 1987
Externally publishedYes

Cite this